We are live on
!
Find out more
RWC
Rare Wolf Capital Portfolio holdings
AUM
$156M
This Fund
S&P 500
This Quarter
Est. Return
-6.54%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$154M
AUM Growth
-$5.71M
(-3.6%)
Cap. Flow
+$5.41M
Cap. Flow
% of AUM
3.51%
Top 10 Holdings %
Top 10 Hldgs %
43.66%
Holding
137
New
14
Increased
46
Reduced
28
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.49M |
| 2 |
ServiceNow
NOW
|
+$1.6M |
| 3 |
Adobe
ADBE
|
+$1.37M |
| 4 |
Hercules Capital
HTGC
|
+$1.24M |
| 5 |
WisdomTree Floating Rate Treasury Fund
USFR
|
+$954K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$1.91M |
| 2 |
Charter Communications
CHTR
|
+$1.37M |
| 3 |
Dow Inc
DOW
|
+$1.26M |
| 4 |
Pfizer
PFE
|
+$1.13M |
| 5 |
Tesla
TSLA
|
+$1.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.76% |
| 2 | Communication Services | 17.8% |
| 3 | Consumer Discretionary | 9.72% |
| 4 | Healthcare | 7.03% |
| 5 | Financials | 6.57% |
Similar funds
PFO
TI
BWM
AIS
BCM
CFG
IWA
GSWA
Rare Wolf Capital's Q1 2026 Portfolio in Review
As of Q1 2026, Rare Wolf Capital held 137 positions worth $154M, down 3.6% from $160M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Rare Wolf Capital deployed $5.41M of net new capital in Q1 2026, opening 14 new positions and adding to 46 existing holdings. Its largest new stake was Intuit: 1,365 shares worth $590K.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Pfizer, an estimated $1.13M trimmed.
- Rare Wolf Capital's largest Q1 2026 buy was Intuit: 1,365 shares worth $590K.
- Rare Wolf Capital added most to Microsoft in Q1 2026, an estimated $2.49M increase.
- Rare Wolf Capital's biggest Q1 2026 reduction was Pfizer, cutting an estimated $1.13M.
- Rare Wolf Capital fully exited Novo Nordisk in Q1 2026, selling an estimated $1.91M.
- Rare Wolf Capital's ten largest holdings make up 44% of its $154M portfolio in Q1 2026.
- Rare Wolf Capital opened 14 new positions and closed 10 in Q1 2026.
- Rare Wolf Capital's portfolio value fell 3.6% quarter-over-quarter to $154M.
Based on Rare Wolf Capital's 13F filing for Q1 2026, filed 14 May 2026.